Risk of thyroid nodular disease and thyroid cancer in patients with acromegaly - Meta-analysis and systematic review

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Wolinski, Kosma ^a   Czarnywojtek, Agata ^a   Ruchala, Marek ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ACROMEGALY; ARTICLE; CANCER RISK; CASE CONTROL STUDY; DISEASE ASSOCIATION; DISEASE REGISTRY; ECHOGRAPHY; HIGH RISK POPULATION; HUMAN; PREVALENCE; RISK ASSESSMENT; SYSTEMATIC REVIEW; THYROID CANCER; THYROID GLAND EXAMINATION; THYROID NODULE;

ACROMEGALY; ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; REGISTRIES; RISK FACTORS; THYROID NODULE;

EID: 84895826931     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088787     Document Type: Article

References (35)

1. Ruchała M, Szczepanek-Parulska E, Komorska-Piotrowiak E. (2011) Diagnostyka i leczenie akromegalii. Oncoreview 4: 240-247.
2. Colao A, Ferone D, Marzullo P, Lombardi P. (2004) Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management. Endocr Rev 25: 102-152. (Pubitemid 38269977)
3. Golkowski F, Krzentowska-Korek A, Baldys-Waligorska A, Hubalewska-Dydejczyk A. (2011) Goiter, cardiovascular and metabolic disorders in patients with acromegaly. Endocr Regul 45: 191-197.
4. Ruchała M, Szczepanek-Parulska E, Fularz M, Woliński K. (2012) Risk of neoplasms in acromegaly. Contemp Oncol (Pozn) 16: 111-117.
5. Rokkas T, Pistiolas D, Sechopoulos P, Margantinis G, Koukoulis G. (2008) Risk of colorectal neoplasm in patients with acromegaly: A meta-analysis. World J Gastroenterol 14: 3484-3489.
6. Jenkins PJ, Besser M. (2001) Acromegaly and Cancer: A Problem. J Clin Endocrinol Metab 86: 2935-2941.
7. Terzolo M, Reimondo G, Gasperi M, Cozzi R, Pivonello R, et al. (2005) Colonoscopic screening and follow-up in patients with acromegaly: a multicenter study in Italy. J Clin Endocrinol Metab 90: 84-90. (Pubitemid 40116638)
8. Scaroni C, Selice R, Benedini S, De Menis E, Arosio M, et al. (2008) Adrenal morpho-functional alterations in patients with acromegaly. J Endocrinol Invest 31: 602-606.
9. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. (2009) Introduction to Meta-analysis. John Wiley & Sons, Ltd, Chichester, UK.
10. Wüster C, Steger G, Schmelzle A, Gottswinter J, Minne HW, et al. (1991) Increased incidence of euthyroid and hyperthyroid goiters independently of thyrotropin in patients with acromegaly. Horm Metab Res 23: 131-134.
11. Cheung NW, Boyages SC. (1997) The thyroid gland in acromegaly: an ultrasonographic study. Clin Endocrinol (Oxf) 46: 545-549. (Pubitemid 27286926)
12. Junik R, Sawicka J, Kozak W, Gembicki M. (1997) Thyroid volume and function in patients with acromegaly living in iodine deficient areas. J Endocrinol Invest, 20, 134-137. (Pubitemid 27263284)
13. Cannavò S, Squadrito S, Finocchiaro MD, Curtò L, Almoto B, et al. (2000) Goiter and impairment of thyroid function in acromegalic patients: basal evaluation and follow-up. Horm Metab Res 32: 190-195. (Pubitemid 30353755)
14. dos Santos MC, Nascimento GC, Nascimento AG, Carvalho VC, Lopes MH, et al. (2013) Thyroid cancer in patients with acromegaly: a case-control study. Pituitary 16: 109-114.
15. Herrmann BL, Baumann H, Janssen OE, Görges R, Schmid KW, et al. (2004) Impact of disease activity on thyroid diseases in patients with acromegaly: basal evaluation and follow-up. Exp Clin Endocrinol Diabetes 112: 225-230. (Pubitemid 38679265)
16. Gasperi M, Martino E, Manetti L, Arosio M, Porretti S, et al. (2002) Acromegaly Study Group of the Italian Society of Endocrinology. Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study. J Endocrinol Invest 25: 240-245. (Pubitemid 34295879)
17. Popovic V, Damjanovic S, Micic D, Nesovic M, Djurovic M, et al. (1998) Increased incidence of neoplasia in patients with pituitary adenomas. The Pituitary Study Group. Clin Endocrinol (Oxf) 49: 441-445. (Pubitemid 28475335)
18. Barzilay J, Heatley GJ, Cushing GW. (1991) Benign and malignant tumors in patients with acromegaly. Arch Intern Med 151: 1629-1632.
19. Rogozinski A, Furioso A, Glikman P, Junco M, Laudi R, et al. (2012) Thyroid nodules in acromegaly. Arq Bras Endocrinol Metabol 56: 300-304.
20. Gullu BE, Celik O, Gazioglu N, Kadioglu P. (2010) Thyroid cancer is the most common cancer associated with acromegaly. Pituitary 13: 242-248.
21. Anagnostis P, Efstathiadou ZA, Polyzos SA, Adamidou F, Slavakis A, et al. (2011) Acromegaly: presentation, morbidity and treatment outcomes at a single centre. Int J Clin Pract 65: 896-902.
22. Bałdys-Waligórska A, Krzentowska A, Gołkowski F, Sokołowski G, Hubalewska-Dydejczyk A. (2010) The prevalence of benign and malignant neoplasms in acromegalic patients. Endokrynol Pol 61: 29-34.
23. Ruchala M, Skiba A, Gurgul E, Uruski P, Wasko R, et al. (2009) The occurrence of thyroid focal lesions and a need for fine needle aspiration biopsy in patients with acromegaly due to an increased risk of thyroid cancer. Neuro Endocrinol Lett 30: 382-386.
24. Kurimoto M, Fukuda I, Hizuka N, Takano K. (2008) The prevalence of benign and malignant tumors in patients with acromegaly at a single institute. Endocr J 55: 67-71. (Pubitemid 351520181)
25. Bolanowski M, Zatonska K, Kaluzny M, Zielinski G, Bednarek-Tupikowska G, et al. (2006) A follow-up of 130 patients with acromegaly in a single centre. Neuro Endocrinol Lett 27: 828-832. (Pubitemid 46138648)
26. Tita P, Ambrosio MR, Scollo C, Carta A, Gangemi P, et al. (2005) High prevalence of differentiated thyroid carcinoma in acromegaly. Clin Endocrinol (Oxf) 63: 161-167. (Pubitemid 41097984)
27. Higuchi Y, Saeki N, Iuchi T, Uchino Y, Tatsuno I, et al. (2000) Incidence of malignant tumors in patients with acromegaly. Endocr J 47 Suppl: 57-60.
28. Kasagi K, Shimatsu A, Miyamoto S, Misaki T, Sakahara H, et al. (1999) Goiter associated with acromegaly: sonographic and scintigraphic findings of the thyroid gland. Thyroid 9: 791-796. (Pubitemid 29409663)
29. Nabarro JDN. (1987) Acromegaly. Clin Endocrinol (Oxf) 26: 481-512.
30. Mestron A, Webb SM, Astorga R, Benito P, Catala M, et al. (2004) Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA). Eur J Endocrinol 151: 439-446. (Pubitemid 39430260)
31. Baris D, Gridley G, Ron E, Weiderpass E, Mellemkjaer L, et al. (2002) Acromegaly and cancer risk: a cohort study in Sweden and Denmark. Cancer Causes Control 13: 395-400. (Pubitemid 34666594)
32. Orme SM, McNally RJ, Cartwright RA, Belchetz PE. (1998) Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. J Clin Endocrinol Metab 83: 2730-2734. (Pubitemid 28493768)
33. Ron E, Gridley G, Hrubec Z, Page W, Arora S, et al. (1991) Acromegaly and gastrointestinal cancer. Cancer 68: 1673-1677.
34. Tan GH, Gharib H. (1997) Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med 126: 226-231. (Pubitemid 27061578)
35. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, et al. (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339: b2700.